Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Discover why keeping cash can be a safer alternative to bank savings. Make informed decisions about your financial security.
25,924 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Investors are watching Nomad Foods navigate a tough year. While the stock has fallen, there are hidden strengths and ...
Tilray Brands is targeting a milestone $1.2 billion in annual revenue next year. This article digs into how the compa...
Income-focused investing is making waves in 2026. This high-yielding dividend beating ETF has shown resilience as bro...
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Ted Turner's launch of CNN and the dawn of nonstop coverage reshaped investing and budgeting for households. This pie...
A seasoned fund trimmed a big winner after a meteoric run. This article breaks down the why behind the move, the numb...
Sandisk stock popped again today, but what’s really behind the move? This article breaks down the sector forces, the ...
Palantir stock down this year has rattled investors. This guide breaks down the fundamentals, what the pullback means...
SoundHound AI is pursuing an enterprise voice AI niche built on data ownership and brand protection. This article bre...
Flaharty Asset Management just expanded its exposure to a short-duration fixed-income strategy by buying a sizable st...
When a packaging company posts stronger results, investors take notice. This piece explains why karat packaging stock...